Though strong evidence suggests the gut microbiota contributes to colorectal cancer (CRC) onset and/or progression, there is no universal signature of a gut microbe or microbiota associated with the disease. The functional capability of gut communities could be more...

By 2030 colorectal cancer will be the leading cause of cancer deaths in individuals aged 20-49. Young-onset CRC differs from average age onset.  Young-onset disease is often more aggressive, presents on the left side of the colon rather than the right, and often...

Most research in cancer microbiomes is carried out in European and North American patients. Patterns in low- and middle-income countries are often assumed based on results from richer countries, despite different diets, living conditions and cancer rates. We...